Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013762-25-004101
Filing Date
2025-03-28
Accepted
2025-03-28 16:12:14
Documents
1
Period of Report
2025-03-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-68923.html 4  
1 PRIMARY DOCUMENT marketforms-68923.xml 4 3912
  Complete submission text file 0001013762-25-004101.txt   5593
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

EIN.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ARTARA THERAPEUTICS, INC. 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address
Zummo Jacqueline (Reporting) CIK: 0001798929 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 25786365